AI and lab tests aim to find best cancer treatment in two weeks
NCT ID NCT07167381
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 27 times
Summary
This study is testing a new approach called xDRIVE that combines lab tests on tumor samples with artificial intelligence to suggest personalized cancer treatments. It involves 210 Florida patients with cancers that have come back or not responded to standard therapy, including children and underserved groups. The main goal is to see if treatment recommendations can be returned within two weeks, which would show the approach is practical for real-world use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
First Ascent Biomedical
RECRUITINGMiami, Florida, 33183, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Florida International University
ACTIVE_NOT_RECRUITINGMiami, Florida, 33199, United States
Conditions
Explore the condition pages connected to this study.